Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Net Loss	$ (1,652,700)	$ (597,800)
Depreciation and amortization	209,600	135,500
Stock-based compensation expense	330,200	390,500
Change in fair value of derivative instruments – warrants	(1,611,200)	(1,319,200)
Accretion of warrants liability for consulting services	(66,000)	(14,100)
Accretion of equity warrants for consulting services, net of forfeitures	(3,600)
Revenue deferred to future periods	1,709,100	1,839,400
Recognition of deferred revenue	(2,250,300)	(2,053,800)
Changes in severance liability	(62,900)	(56,000)
Changes in deferred rent	(2,300)	(13,000)
Changes to allowance for doubtful accounts	(21,600)	(9,300)
Changes in operating assets and liabilities:
Accounts receivable	266,900	122,300
Prepaid expenses	(68,000)	46,200
Accounts payable and accrued expenses	(57,300)	127,300
Other assets		14,500
Net Cash Used in Operating Activities	(3,280,100)	(1,387,500)
Cash Flows Used In Investing Activities:
Capital expenditures	(40,800)	(48,000)
Capitalized software development costs		(427,800)
Net Cash Used In Investing Activities	(40,800)	(475,800)
Cash Flows Provided By Financing Activities:
Proceeds from private placement of stock and warrants, net of issuance costs	3,370,000
Proceeds from exercise of warrants	260,000	2,551,300
Proceeds from exercise of employee stock options	47,800	112,400
Net Cash Provided By Financing Activities	3,677,800	2,663,700
Net Increase in Cash	356,900	800,400
Cash - Beginning of Period	2,430,700	3,960,600
Cash - End of Period	$ 2,787,600	$ 4,761,000